Search or
𝛼SK
𝛼SKbullish
IKang: Endgame Approaching, But Fair Price Is Distant
570 Views26 Mar 2018 03:18
iKang Healthcare Group (ADR) (KANG US) 's December quarter results provide updated benchmarks for evaluating Yunfeng and Alibaba's US$20/ADS offer...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »Trending Collections
More »Trending Insights
More »- Dongfeng (489 HK)'s Privatisation And EV Backdoor Listing
- Nissan Motor Placement - Discount Is Enticing but Track Record and Momentum Aren’t Great
- S&P/ASX Index Rebalance Preview (Sep 25): Potential Changes if Methodology Is Updated
- Ohayo Japan | Stocks Retreat Ahead of Nvidia Earnings
- NIFTY50/NEXT50 Index Rebalance: Bunch Of (Mostly) Expected Changes; Positioning Increases
Top Unpaywalled Insights
More »- At the US-Korea Summit, Samsung’s Next Move Could Reshape the US Chipboard
- DeFi, On-Chain Truth, and the Petrodollar 2.0
- [IO Technicals 2025/34] Iron Ore Braces for Bullish Shift After Six-Day Slide
- SoilBuild Construction Group Limited: Soilbuild’s 1HFY25 Earnings Soar Past FY24
- India-China Economic Relations: Navigating Massive Imbalances and Strategic Dependencies
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Good Results Cut Both Ways03 Oct 2018
- IKang Healthcare Buyout: The Ground Is Shakier07 Sep 2018
- Updated Proxy Filed and Q4 Results Released27 Jun 2018
- IKang: Endgame Approaching, But Fair Price Is Distant26 Mar 2018
- Sell-Side Analysts Resurface: What to Think?21 Dec 2017
- The Elephant in the Room27 Sep 2017
x